TuHURA Biosciences, Inc. (HURA)
NASDAQ: HURA · Real-Time Price · USD
3.820
-0.170 (-4.26%)
At close: May 12, 2025, 4:00 PM
3.900
+0.080 (2.09%)
After-hours: May 12, 2025, 4:07 PM EDT
TuHURA Biosciences Employees
TuHURA Biosciences had 19 employees as of December 31, 2024. The number of employees increased by 18 or 1,800.00% compared to the previous year.
Employees
19
Change (1Y)
18
Growth (1Y)
1,800.00%
Revenue / Employee
n/a
Profits / Employee
-$1,192,083
Market Cap
166.86M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 19 | 18 | 1,800.00% |
| Dec 31, 2023 | 1 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
HURA News
- 7 days ago - TuHURA Biosciences, Inc. Initiates Phase 1b/2a Study of IFx-Hu2.0 as an Adjunctive Therapy to Keytruda® (pembrolizumab) in First Line Treatment for Metastatic Merkel Cell Carcinoma of Unknown Primary Origin (MCCUP) - PRNewsWire
- 14 days ago - TuHURA Biosciences and Kineta Present Updated Results from Kineta's Phase I-II Study of KVA12123 and TuHURA's Mechanism of IFx-Hu2.0 Responses After Anti-PD-1 Therapy Failure in Advanced Melanoma at the American Association for Cancer Research Annual Meeting - PRNewsWire
- 4 weeks ago - TuHURA Biosciences, Inc. Announces Abstracts Accepted for Poster Presentation at the 2025 AACR Annual Meeting - PRNewsWire
- 5 weeks ago - TuHURA Biosciences, Inc. Appoints Dr. Bertrand Le Bourdonnec as Executive Vice President, Head of Drug Discovery, Early Development, and Program Management - PRNewsWire
- 5 weeks ago - TuHURA Biosciences, Inc. Reports Financial Results for Fiscal Year 2024 and Provides Corporate Update - PRNewsWire
- 2 months ago - TuHURA Biosciences, Inc Appoints Craig L. Tendler M.D. - Accesswire
- 2 months ago - TuHURA Biosciences, Inc. to Present at the 37th Annual ROTH Conference - Accesswire
- 2 months ago - TuHURA Biosciences, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference - Accesswire